Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RevMedx is a privately held U.S. medical device company focused on hemorrhage-control products for military, tactical, EMS, and civilian first-responder settings. The company designs, develops, and manufactures trauma-care devices intended to rapidly control life-threatening bleeding in prehospital and battlefield environments. Its commercial product portfolio includes the prescription XSTAT expanding sponge devices for junctional hemorrhage, XGAUZE trauma dressings, AirWrap compression bandages, and TX Series ratcheting tourniquets. RevMedx emphasizes field-ready design, rapid application, and quality systems aligned with regulated medical-device standards. The company appears to operate as a commercial-stage trauma device manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RevMedx.